178 related articles for article (PubMed ID: 24443980)
1. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway.
Ma X; Zou J; He L; Zhang Y
Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980
[TBL] [Abstract][Full Text] [Related]
2. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
3. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren's syndrome.
Zoukhri D; Hodges RR; Dartt DA
Clin Immunol Immunopathol; 1998 Nov; 89(2):126-33. PubMed ID: 9787114
[TBL] [Abstract][Full Text] [Related]
4. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
Sullivan DA; Edwards JA
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
8. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
[TBL] [Abstract][Full Text] [Related]
9. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.
Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298
[TBL] [Abstract][Full Text] [Related]
10. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
11. Sex Effects on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
Tellefsen S; Morthen MK; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5599-5614. PubMed ID: 30481277
[TBL] [Abstract][Full Text] [Related]
12. Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
Morthen MK; Tellefsen S; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2181-2197. PubMed ID: 31108549
[TBL] [Abstract][Full Text] [Related]
13. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ signaling by cholinergic and alpha1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome.
Zoukhri D; Hodges RR; Rawe IM; Dartt DA
Clin Immunol Immunopathol; 1998 Nov; 89(2):134-40. PubMed ID: 9787115
[TBL] [Abstract][Full Text] [Related]
16. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
17. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.
Zoukhri D; Macari E; Choi SH; Kublin CL
J Neurochem; 2006 Jan; 96(1):126-35. PubMed ID: 16300639
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome.
Ono M; Rocha FJ; Sullivan DA
Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837
[TBL] [Abstract][Full Text] [Related]
19. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models.
Hawley D; Tang X; Zyrianova T; Shah M; Janga S; Letourneau A; Schicht M; Paulsen F; Hamm-Alvarez S; Makarenkova HP; Zoukhri D
Sci Rep; 2018 Jul; 8(1):9919. PubMed ID: 29967327
[TBL] [Abstract][Full Text] [Related]
20. Normal and Sjogren's syndrome models of the murine lacrimal gland studied at single-cell resolution.
Rattner A; Heng JS; Winer BL; Goff LA; Nathans J
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2311983120. PubMed ID: 37812717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]